Voxel-based morphometry (VBM) is a widely used automated technique for the analysis of neuroanatomical images. This work, which reviews important VBM clinical findings of the last few years, is divided into two main sections. After briefly introducing VBM methodology, in the first part, VBM findings on neurological and psychiatric diseases have been discussed separately. The reported studies were divided into studies that examine the diagnostic value of VBM results and their usefulness for the differential diagnosis between two disorders; studies investigating the potential of VBM for the diagnosis in an early stage of the illness, and studies that examine the utility of VBM for predicting the transition from prodromal phase to full-blown disease. In the second part, this review focuses on the most recent findings on the single-case approach. This analysis is useful for promoting the translational impact of VBM results in clinical practice, where clinicians need to make inferences at the level of the individual patient. Finally, within the single-case approach, a paragraph is dedicated to the potential forensic applications of VBM. Indeed, if used to support and integrate results obtained with classical forensic evaluations, VBM may provide objective data that could be used to reduce controversy in forensic psychiatric evaluations of mental insanity. In this second part, particular emphasis is given to the problem of results interpretation, which should be based mainly on the presence of anatomoclinical correlation. The review finishes with a provocative note reporting an interesting result of a single-case VBM analysis that highlights the risk to fall into the “reverse inference” reasoning. This example has been chosen because it effectively highlights the risks that are encountered when this technique is inappropriately used.
Neurocognitive disturbances in Parkinson's disease (PD) are common and can impact several aspects of daily functioning and quality of life. This multicenter study evaluated the efficacy of a novel immersive virtual reality (iVR) cognitive training (CT) targeting executive functions (EF)-planning, shifting, and updating abilities-to improve prospective memory (PM) in PD patients with mild cognitive impairment (PD-MCI). Potential transfer effects were also examined in healthy older adults (HC). In this double-blind randomized controlled trial, 30 PD-MCI were randomized into a 4-week EF-training (PD-CT) or active placebo (PD-AP), delivered at home through a combined approach of telemedicine and iVR. Similarly, 30 age- and education-matched HC were assigned to the EF-training (HC-CT) or active placebo (HC-AP). The PD-CT group exhibited significant improvements in PM (in time-based and verbal-response tasks) and in EF, particularly in inhibition abilities (in the Stroop test), with effects sustained at 2-month follow-up. These gains were absent in the PD-AP group. Regression analyses revealed that PM enhancements were primarily driven by improved inhibition and shifting abilities. The EF-training was effective also in the older adults, the HC-CT group showed improvements in planning abilities (in the Zoo Map test) at post-intervention and 2-month follow-up, while no cognitive gains were observed in the HC-AP group. This innovative iVR-based EF-training effectively enhances PM and inhibition in PD-MCI, and planning abilities in healthy older adults, demonstrating its potential for improving cognition in both populations. These findings support the use of iVR and telemedicine for accessible, personalized non-pharmacological cognitive interventions.